Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
0.781
+0.010 (1.31%)
At close: Dec 20, 2024, 4:00 PM
0.795
+0.014 (1.79%)
After-hours: Dec 20, 2024, 5:30 PM EST
Lucid Diagnostics Market Cap
Lucid Diagnostics has a market cap or net worth of $43.30 million as of December 20, 2024. Its market cap has decreased by -29.94% in one year.
Market Cap
43.30M
Enterprise Value
40.67M
1-Year Change
-29.94%
Ranking
Category
Stock Price
$0.78
Market Cap Chart
Since the IPO on October 14, 2021, Lucid Diagnostics's market cap has decreased from $514.14M to $43.30M, a decrease of -91.58%. That is a compound annual growth rate of -54.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 43.30M | -27.45% |
| Dec 29, 2023 | 59.69M | 12.22% |
| Dec 30, 2022 | 53.19M | -73.09% |
| Dec 31, 2021 | 197.66M | -61.55% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Omega Therapeutics | 44.98M |
| DIH Holding US | 44.56M |
| enVVeno Medical | 44.37M |
| Rapid Micro Biosystems | 43.03M |
| CollPlant Biotechnologies | 42.10M |
| Gain Therapeutics | 41.64M |
| Cardio Diagnostics Holdings | 41.25M |
| Xilio Therapeutics | 41.23M |